Medicine guide
Victrelis
·
- Prescription status not stated
- Antibiotics, antivirals and antifungals taken into the body
- Active substance
- Boceprevir
- Made by
- Merck Sharp Dohme Ltd
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Victrelis is indicated for the treatment of chronic hepatitis-C (CHC) genotype-1 infection, in combination with peginterferon alfa and ribavirin, in adult patients with compensated liver disease who are previously untreated or who have failed previous therapy.
From the official label · 2026-09-30 · European Medicines Agency
Details
| Made by | Merck Sharp Dohme Ltd |
|---|---|
| Active substance | Boceprevir |
| Used in | Antibiotics, antivirals and antifungals taken into the body |
| Classification | J05AE · Antibiotics, antivirals and antifungals taken into the body |
| Authorised on | 2011-07-18 |
| Last updated by the regulator | 2018-07-31 |
| EMA product number | EMEA/H/C/002332 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).